ZyVersa Therapeutics, Inc. (ZVSA)

NASDAQ: ZVSA · Real-Time Price · USD

0.5900

-0.0500 (-7.81%)

At close: Jul 10, 2025, 4:00 PM

0.5721

-0.0179 (-3.03%)

After-hours: Jul 10, 2025, 7:59 PM EDT

ZyVersa Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	1.61	1.53	3.14	5.9	0.33	0.17
Cash & Short-Term Investments	1.61	1.53	3.14	5.9	0.33	0.17
Cash Growth	-20.75%	-51.21%	-46.84%	1696.27%	88.11%	-
Prepaid Expenses	0.5	0.18	0.22	0.23	0.11	0.16
Other Current Assets	-	-	-	0.24	0.38	-
Total Current Assets	2.11	1.72	3.35	6.36	0.81	0.34
Property, Plant & Equipment	-	-	0.01	0.12	0.03	0.04
Goodwill	-	-	-	11.9	-	-
Other Intangible Assets	18.65	18.65	18.65	100.09	-	-
Long-Term Deferred Charges	0.05	0.06	-	-	-	-
Other Long-Term Assets	0.18	0.18	0.1	0.05	0.29	0.31
Total Assets	20.99	20.6	22.11	118.51	1.13	0.69
Accounts Payable	9.6	9.34	8.43	6.03	2	2.31
Accrued Expenses	2.39	1.89	1.25	0.8	0.75	1.16
Current Portion of Long-Term Debt	-	-	-	-	9.15	2.13
Current Portion of Leases	-	-	0.01	0.11	-	-
Current Income Taxes Payable	-	-	-	0.11	-	-
Other Current Liabilities	0.01	0.01	0.51	1.15	1.73	1.96
Total Current Liabilities	12	11.23	10.19	8.19	13.63	7.56
Long-Term Debt	-	-	-	-	-	1.69
Long-Term Deferred Tax Liabilities	0.85	0.85	0.84	10.32	-	-
Other Long-Term Liabilities	-	-	-	0.33	0.33	0.33
Total Liabilities	12.86	12.08	11.04	18.84	13.96	9.57
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	123.03	121.16	114.3	104.58	40.07	35.92
Retained Earnings	-114.89	-112.63	-103.22	-4.92	-52.9	-44.81
Treasury Stock	-0.01	-0.01	-0.01	-	-	-
Total Common Equity	8.13	8.52	11.07	99.66	-12.83	-8.89
Shareholders' Equity	8.13	8.52	11.07	99.66	-12.83	-8.89
Total Liabilities & Equity	20.99	20.6	22.11	118.51	1.13	0.69
Total Debt	-	-	0.01	0.11	9.15	3.82
Net Cash (Debt)	1.61	1.53	3.13	5.79	-8.82	-3.64
Net Cash Growth	-20.75%	-51.07%	-45.99%	-	-	-
Net Cash Per Share	0.93	1.38	32.09	0.25	-3.65	-53.94
Filing Date Shares Outstanding	4.77	2.57	0.83	0.12	24.17	0.07
Total Common Shares Outstanding	2.57	2.51	0.41	0.03	24.17	0.07
Working Capital	-9.89	-9.52	-6.84	-1.83	-12.81	-7.22
Book Value Per Share	3.17	3.40	27.33	3868.91	-0.53	-131.63
Tangible Book Value	-10.52	-10.13	-7.57	-12.32	-12.83	-8.89
Tangible Book Value Per Share	-4.10	-4.04	-18.69	-478.20	-0.53	-131.63
Machinery	-	0.05	0.05	0.05	0.05	0.05

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q